One in nine people may be able to control their viral load after stopping treatment, US study finds
The kick that didn’t kill: first-ever randomised HIV cure study fails to eliminate infected cells
Will an HIV vaccine that protected two-thirds of monkeys do the same for humans?
Very early treatment in children limits the HIV reservoir
Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys
European Cure Review concentrates on HIV therapeutic vaccines
ABX464 reduces HIV reservoir but doesn’t delay viral rebound
Why curing HIV may be like curing cancer – and may be as difficult
What marks out HIV controllers from others?
